These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28775928)

  • 81. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.
    Minniti G; Lanzetta G; Scaringi C; Caporello P; Salvati M; Arcella A; De Sanctis V; Giangaspero F; Enrici RM
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):93-9. PubMed ID: 22079725
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.
    Kessler AF; Linsenmann T; Westermaier T; Wolber W; Weiland J; Monoranu CM; Breun M; Hagemann C; Ernestus RI; Löhr M
    Oncol Lett; 2020 Jan; 19(1):557-561. PubMed ID: 31897171
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
    Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
    JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV; Myrehaug SD; Chang MG; Holdford DJ; Smith S; Shih J; Tofilon PJ; Fine HA; Camphausen K
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):986-992. PubMed ID: 26194676
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
    Franceschi E; Depenni R; Paccapelo A; Ermani M; Faedi M; Sturiale C; Michiara M; Servadei F; Pavesi G; Urbini B; Pisanello A; Crisi G; Cavallo MA; Dazzi C; Biasini C; Bertolini F; Mucciarini C; Pasini G; Baruzzi A; Brandes AA;
    J Neurooncol; 2016 May; 128(1):157-162. PubMed ID: 26943851
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma.
    Faye MD; Easaw J; De Robles P; Agnihotram R; Torres-Vasquez A; Lamonde F; Petrecca K; Owen S; Panet-Raymond V; Shenouda G; Souhami L; Azam M; Hossain B; Alkass J; Sabri S; Abdulkarim B
    Neurooncol Adv; 2023; 5(1):vdad106. PubMed ID: 37771465
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.
    Ney DE; Carlson JA; Damek DM; Gaspar LE; Kavanagh BD; Kleinschmidt-DeMasters BK; Waziri AE; Lillehei KO; Reddy K; Chen C
    J Neurooncol; 2015 Mar; 122(1):135-43. PubMed ID: 25524817
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.
    Elinzano H; Glantz M; Mrugala M; Kesari S; Piccioni DE; Kim L; Pan E; Yunus S; Coyle T; Timothy K; Evans D; Mantripragada K; Boxerman J; DiPetrillo T; Donahue JE; Hebda N; Mitchell KM; Rosati KL; Safran H
    Am J Clin Oncol; 2018 Feb; 41(2):159-162. PubMed ID: 26658237
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Glioblastoma in Elderly Patients: Current Management and Future Perspectives.
    Minniti G; Lombardi G; Paolini S
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30857221
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis.
    Alnahhas I; Alsawas M; Rayi A; Palmer JD; Raval R; Ong S; Giglio P; Murad MH; Puduvalli V
    Neurooncol Adv; 2020; 2(1):vdaa082. PubMed ID: 33150334
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial.
    Compter I; Eekers DBP; Hoeben A; Rouschop KMA; Reymen B; Ackermans L; Beckervordersantforth J; Bauer NJC; Anten MM; Wesseling P; Postma AA; De Ruysscher D; Lambin P
    Autophagy; 2021 Sep; 17(9):2604-2612. PubMed ID: 32866424
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study.
    Bokstein F; Blumenthal D; Limon D; Harosh CB; Ram Z; Grossman R
    Front Oncol; 2020; 10():411. PubMed ID: 32373508
    [No Abstract]   [Full Text] [Related]  

  • 96. Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors.
    Mallick S; Gandhi AK; Joshi NP; Kumar A; Puri T; Sharma DN; Haresh KP; Gupta S; Julka PK; Rath GK; Sarkar C
    Indian J Med Paediatr Oncol; 2015; 36(2):99-104. PubMed ID: 26157286
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients.
    Howard CM; Valluri J; Alberico A; Julien T; Mazagri R; Marsh R; Alastair H; Cortese A; Griswold M; Wang W; Denning K; Brown L; Claudio PP
    Transl Oncol; 2017 Apr; 10(2):241-254. PubMed ID: 28199863
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
    Napoleoni L; Cortellini A; Cannita K; Parisi A; Dal Mas A; Calvisi G; Venditti O; Baldi PL; Cocciolone V; Ricci A; Ficorella C
    Bioengineering (Basel); 2019 Jan; 6(1):. PubMed ID: 30678211
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
    Bunevicius A; Pikis S; Kondziolka D; Patel DN; Bernstein K; Sulman EP; Lee CC; Yang HC; Delabar V; Mathieu D; Cifarelli CP; Arsanious DE; Dahshan BA; Weir JS; Speckter H; Mota A; Tripathi M; Kumar N; Warnick RE; Sheehan JP
    J Neurosurg; 2022 Jul; 137(1):42-50. PubMed ID: 34740186
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis.
    Klement RJ; Popp I; Kaul D; Ehret F; Grosu AL; Polat B; Sweeney RA; Lewitzki V
    J Neurooncol; 2022 Jan; 156(2):407-417. PubMed ID: 34940951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.